Harsh Desai, Mohammed Maan Al-Salihi, Rami Z Morsi, Omar R Vayani, Sachin A Kothari, Sonam Thind, Julián Carrión-Penagos, Archit Baskaran, Ammar Tarabichi, Veronica A Bonderski, James E Siegler, Mary Hahn, Elisheva R Coleman, James R Brorson, Scott J Mendelson, Ali Mansour, Guilherme Dabus, Michael Hurley, Shyam Prabhakaran, Italo Linfante, Tareq Kass-Hout
BACKGROUND: The optimal antiplatelet therapy regimen for certain neuroendovascular procedures remains unclear. This study investigates the safety and feasibility of intravenous dose-adjusted cangrelor in patients undergoing acute neuroendovascular interventions. METHODS: We conducted a retrospective chart review of all consecutive patients on intravenous cangrelor for neuroendovascular procedures between September 1, 2020, and March 13, 2022. We also conducted an updated systematic review and meta-analysis using PubMed, Scopus, Web of Science, Embase and the Cochrane Library up to February 22, 2023...
2023: Frontiers in Neurology